Walgreens gets serious about its move into healthcare

Walgreens gets serious about its move into healthcare

Posted on

Walgreens Boots Alliance
WBA,
+6.04%

is doubling down on its big healthcare bet as the pharmacy giant upped a long-term sales target for its growing healthcare business and described its plans to become a leader in the American medical system.  

The company has spent the last few years building out the business it calls U.S. Healthcare, which includes everything from the clinics it operates through its majority stake in VillageMD to Shields, a specialty pharmacy that services health systems.

Walgreens is “well underway in our transformation to a consumer-centric healthcare company,” Walgreens CEO Rosalind Brewer told investors during an earnings call Thursday. 

The U.S. Healthcare business unit generated $622 million in sales in the fourth quarter of the year and a total of $1.8 billion for fiscal 2022. But Walgreens said it expects a significant increase in sales out of this business within the next three years — in fact, it raised the sales target for its healthcare business unit to $11 billion to $12 billion in fiscal 2025, up from $9 billion to $10 billion. Walgreens said it also expects the business to be profitable by fiscal 2024.

The company’s stock was up 5.7% in Wednesday afternoon trading.

Walgreens has made three deals key to its healthcare strategy: Shields; VillageMD, with which it currently operates 342 VillageMD clinics and 152 co-located clinics; and CareCentrix, which provides home-health services like nursing, infusion and palliative-care services. The company said earlier this week that it plans to take full ownership of CareCentrix, spending another $392 million.

“We’re creating a nationally scaled healthcare business, which will leverage our entire portfolio to deliver better care at lower costs,” John Driscoll, the new head of the U.S. Healthcare business unit and former CEO of CareCentrix, told investors. “And by focusing our portfolio on these higher-growth markets, we will accelerate the return on our investment and our path to profitability in U.S. Healthcare.”

Walgreens isn’t the only pharmacy chain expanding into uncharted parts of the U.S.’s healthcare system. CVS Health Corp.
CVS,
+2.90%
,
which since 2018 has owned the health insurer Aetna, is also the largest provider of retail health services in the country. It recently acquired home-health provider Signify Health for $8 billion and is reportedly considering an acquisition of Cano Health Inc.
CANO,
+0.17%
,
another home-health provider. At Walmart Health
WMT,
+1.15%
,
you can get an X-ray, dental work or a physical.

All three of these companies have announced plans within the last year to use their stores and clinics as clinical-trial sites. 

Walgreens shares are down 36.1% so far this year, while the benchmark S&P 500
SPX,
+2.80%

has declined 24.9%.

Leave a Reply

Your email address will not be published. Required fields are marked *